samedan logo

home > news > detailed info

How to Identify and Manage Risks in Clinical Trial Supplies and Comparator Sourcing: The Benefits of the Global Reach, Upcoming Webinar Hosted by Xtalks

Clinical Services International

In this free webinar, the featured speakers will explore how comparators are used in different clinical trial phases and the risks associated with the supply chain in each phase

TORONTO (PRWEB) October 30, 2020

Running a successful clinical trial relies heavily on the management of risks within the supply chain. Risk management is an essential part of clinical trials to ensure that sponsors can generate a clear return on investment without disruptions. It’s a complex process of identification and management depending on a number of factors that can impact the effectiveness of the trial. There is no ‘one size fits all’ approach. Each clinical trial has its own complexities based on the comparator, data and stock shortages which can delay timelines and increase costs. Mistakes can prove very expensive and more importantly, put patient safety at risk.

Successful clinical trials need effective supply chain management procedures to make sure risks are identified and managed in a timely manner, so that the required medication is available at the site when needed. Taking a holistic approach to assessing and managing risks makes sure that sponsors can prevent things that will impact the trial and the data generated. There needs to be a robust methodology in place for identifying, evaluating and proactively managing the risks involved in clinical trials. Having the benefit of a global reach and multiple sources can make a tremendous difference to the options available.

So, what are the risks involved in clinical trial supplies and comparator sourcing and how can you manage these risks to ensure a successful clinical trial on a global scale?

Join Vanessa Dekou, PhD, Managing Director, Clinical Services International (CSI) and Kotaro Yoshizawa, Chief Representative Japan-Global, CSI in a live webinar on Monday, November 16, 2020 at 9am EST (2pm GMT/UK) to find out.

For more information or to register for this event, visit How to Identify and Manage Risks in Clinical Trial Supplies and Comparator Sourcing: The Benefits of the Global Reach.


Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit
For information about hosting a webinar visit
phone +44 (0)203 954 0517
email Clinical Services International, 50 Sloane Avenue London SW3 3DD United Kingdom
Print this page
Send to a friend
News and Press Releases

Peptilogics Closes $35.4 Million Series B Financing to Further Advance Proprietary Computational Peptide Drug Design and Discovery Platform

PITTSBURGH, PA, Dec. 21, 2020 /PRNewswire/ -- Peptilogics announced today the closing of a $35.4 million Series B financing. The financing was led by Presight Capital, with participation from a new investor syndicate including Founders Fund as well as from existing investor Peter Thiel. The proceeds of the financing will be used to expand Peptilogics’ computational platform and invest in technologies to improve its drug design engine, as well as accelerate development of a pipeline of peptide therapeutics including the Company’s lead clinical asset, PLG0206, which has demonstrated first-in-class safety and best-in-class efficacy.
More info >>

White Papers

Industry Events

12th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology

8-11 February 2021, Vienna, Austria

In continuation of the very successful scientific meetings in Budapest, Paris, Berlin, Florence, Geneva, Barcelona, Malta, Istanbul, Lisbon, Glasgow and Granada, the 12th PBP World will be held in Vienna from 8-11 Feb 2021. This every two year held conference has gained an ever increasing impact among the pharmaceutical scientists: With up to 1000 submitted abstracts and about 1300 participants it has become a well-established major meeting, attracting scientists from all over the world.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement